Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Strongyloidiasis-related lung involvement: too much of a bad thing48
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era46
Editorial introductions42
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel42
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV40
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians40
Surgical management of cystic echinococcosis of the liver37
Skin and soft tissue infections in the elderly33
Complexities of cardiomyopathy in septic shock30
From diagnosis to management: current perspectives on congenital cytomegalovirus infection30
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside29
New therapies for nontuberculous mycobacterial lung infection28
La Crosse virus encephalitis in children28
Fusarium species central nervous system infection28
Corticosteroids for viral central nervous system infections28
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response26
Progress and challenges in human papillomavirus and cervical cancer in southern Africa26
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management25
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients24
Viral meningitis and encephalitis: an update24
Typhoid fever control in the 21st century: where are we now?23
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?23
Tuberculosis molecular bacterial load assay in the management of tuberculosis23
Mycobacterial skin infection23
Mpox in people living with HIV21
Resistant herpes simplex virus infections – who, when, and what's new?21
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention21
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?20
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies20
Tick-borne encephalitis19
CMV antiviral stewardship in transplantation – the next frontier19
Malaria in pregnancy: baby steps19
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach18
Does climate change threaten delivery of HIV care in resource-limited settings?18
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis18
Diagnostic stewardship: what impacts antibiotics use?17
Editorial introductions17
Gut microbiome and its clinical implications: exploring the key players in human health17
Appropriate surgical management in skin and soft tissue infections16
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV16
Diagnostic approach and update on encephalitis16
Using antibiotics wisely16
Interventions for polyoma virus-associated hemorrhagic cystitis16
Risk stratification for selecting empiric antibiotherapy during and after COVID-1915
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles15
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1914
The microbiota in respiratory tract infections: from association to intervention14
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change14
The plumbing problem: rising antimicrobial resistance in building water systems14
Immunotherapeutic approaches to HIV cure and remission14
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections14
Update on the treatment of chronic pulmonary aspergillosis13
Editorial introductions13
The impact of coronavirus disease 2019 on people with HIV13
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential12
Editorial: Pathogenesis and immune response – editorial12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae12
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities12
Interpreting and managing preservation fluids positive for Gram-negative bacteria12
The microbiome as a biomarker of anal precancerous lesions in people with HIV12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives12
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management12
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?12
Childhood tuberculosis12
Data science for pediatric infectious disease: utilizing COVID-19 as a model11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients11
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis11
Short treatment duration for community-acquired pneumonia11
Travellers’ diarrhoea – solidifying our knowledgebase11
An overview of risk factors, management and prevention of cochlear implant infections11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities10
Update on drug treatments for multidrug resistant tuberculosis10
Respiratory metagenomics: route to routine service10
A new era of HIV care for age-associated multimorbidity10
The disease burden of respiratory syncytial virus in Infants10
Burden of influenza in the elderly: a narrative review10
Identifying patients with difficult-to-treat acute bacterial skin infections9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
Urinary tract infections in immunocompromised patients9
Immune responses and severe dengue: what have we learned?9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients9
Antibiotic treatment of acute bacterial skin and skin structure infections9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Neurobrucellosis9
The evolution of knowledge for treating Gram-negative bacterial infections9
Novel techniques in the treatment of skin and soft tissue infection9
Short-course antibiotic strategies for ventilator-associated pneumonia9
Therapeutic agents for the treatment of human mpox9
The role of Gram-negative bacteria in skin and soft tissue infections9
Updates on the neurological manifestations of SARS-CoV-2 infection9
Skin and soft tissue infections in solid organ transplants9
Chagas disease in the immunocompromised host9
0.10725784301758